Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 14/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | RAPGEF3 | O95398 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | GMNN | O75496 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 1.00 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.80 |
| ▸ | PDE4A | P27815 | 1/20 | 0.78 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.78 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.78 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.78 |
| ▸ | MEN1 | O00255 | 1/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclic Adenosine Monophosphate SCHEMBL18716064 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| SCHEMBL15893189 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| SCHEMBL18934079 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| SCHEMBL22434642 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| Cyclic Adenosine Monophosphate SCHEMBL23829653 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| Cyclic Adenosine Monophosphate SCHEMBL23829820 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| Cyclic Adenosine Monophosphate SCHEMBL23829591 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| Cyclic Adenosine Monophosphate SCHEMBL23829670 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| Cyclic Adenosine Monophosphate SCHEMBL23829673 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| Cyclic Adenosine Monophosphate SCHEMBL20912149 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 39158 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4741012-A2 | COMPOSITIONS AND METHODS FOR REDUCING AMYLOID BETA FORMATION AND COMPOSITION THEREFORE | Aribio Co., Ltd. (KR) | 2026-05-13 | — | — | EP | claimed |
| EP-4684005-A1 | OCULAR ORGANOIDS | Koninklijke Nederlandse Akademie van Wetenschappen (NL) | 2026-01-28 | — | — | EP | claimed |
| US-20260021198-A1 | THERAPEUTIC CIRCULAR DNA FORMS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC | 2026-01-22 | — | — | US | claimed |
| US-20260021100-A1 | METHODS FOR TREATING ALZHEIMER DISEASE AND FOR REDUCING AMYLOID BETA FORMATION | ARIBIO CO LTD (KR) | 2026-01-22 | — | — | US | claimed |
| EP-4680726-A2 | STEM CELL AND ORGANOID BASED METHODS FOR DIAGNOSTICS AND OPTIMIZATION OF EMBRYO IMPLANTATION | Simbryo Technologies, Inc. (US) | 2026-01-21 | — | — | EP | claimed |
| US-20260015579-A1 | ARTIFICIAL UTERINE PLATFORM AND APPLICATIONS THEREOF | CALIFORNIA INST OF TECHN (US) | 2026-01-15 | — | — | US | claimed |
| EP-4677063-A1 | METHODS FOR GENERATING ENDOMETRIUM ASSEMBLOIDS | Babraham Institute (GB) | 2026-01-14 | — | — | EP | claimed |
| US-20260007680-A1 | Compounds and Their Use as PDE4 Activators | MIRONID LIMITED (GB) | 2026-01-08 | — | — | US | claimed |
| US-20260001876-A1 | Compounds and Their Use as PDE4 Activators | MIRONID LIMITED (GB) | 2026-01-01 | — | — | US | claimed |
| US-20250388604-A1 | Compounds and Their Use as PDE4 Activators | MIRONID LIMITED (GB) | 2025-12-25 | — | — | US | claimed |
| EP-0081882-B1 | MEDICINE HAVING TRANSPLANT REJECTION AND/OR IMMUNOLOGICAL INFLAMMATION INHIBITING ACTIVITIES, AS WELL AS A METHOD FOR INHIBITING TRANSPLANT REJECTION AND/OR IMMUNOLOGICAL INFLAMMATION | Erasmus Universiteit Rotterdam (NL) | 1986-04-16 | — | — | EP | claimed |
| US-4568676-A | SYNERGISTIC INHIBITION | THOMAS JEFFERSON UNIVERSITY (US) | 1986-02-04 | — | — | US | claimed |
| WO-1985005008-A1 | PEST CONTROLLING COMPOSITIONS | THE GENERAL HOSPITAL CORPORATION (US) | 1985-11-21 | — | — | WO | claimed |
| EP-0071357-B1 | PHARMACEUTICAL AND DIETARY COMPOSITION WHEN USED FOR ENHANCEMENT OF 1-SERIES PG PRODUCTION | EFAMOL LIMITED (GB) | 1985-01-02 | — | — | EP | claimed |
| US-4490371-A | ANTICOAGULANTS, PHOSPHODIESTERASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1984-12-25 | — | — | US | claimed |
| EP-0116948-A2 | (2-Oxo-1,2,3,5-tetrahydroimidazo-(2,1-b)quinazolinyl)-oxyalkyl-amides | SYNTEX (U.S.A.) INC. (US) | 1984-08-29 | — | — | EP | claimed |
| US-4444778-A | ANTISEROTONINE AGENTS | COUGHLIN SHAUN R | 1984-04-24 | — | — | US | claimed |
| EP-0071357-A1 | Pharmaceutical and dietary composition when used for enhancement of 1-series PG production | EFAMOL LIMITED (GB) | 1983-02-09 | — | — | EP | claimed |
| EP-0011828-A1 | Pharmaceutical combinations including hydantoin derivatives, pharmaceutical formulations containing the combinations and methods of making the formulations | THE WELLCOME FOUNDATION LIMITED (GB) | 1980-06-11 | — | — | EP | claimed |
| US-4010148-A | Purified thymosin and process | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 1977-03-01 | — | — | US | claimed |